Home / News / India News / Article /
Pfizer in talks with India on vaccine approval, says CEO
Updated On: 04 May, 2021 10:39 AM IST | New York | IANS
"We are currently discussing with Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country," he said in a video posted on the company website.

Photo used for representational purpose. Pic/AFP
Pfizer is discussing expedited approval of its Covid-19 vaccine with the Indian government, company CEO Alber Bourla said while announcing a donation of medicines worth $70 million to fight the resurgent pandemic. "We are currently discussing with Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country," he said in a video posted on the company website.
He pledged to send enough medicines over the next 90 days "to ensure that every Covid-19 patient in every public hospital across India can have access to them". "These medicines are valued at more than $70 million would be made available immediately and we will work closely with the government and our NGO partners to get them to where hey are need most."


